Xizang Weixinkang Pharmaceutical Co Ltd
603676
Company Profile
Business description
Xizang Weixinkang Pharmaceutical Co Ltd is engaged in research & development, production and sales of chemical pharmaceutical preparations and their raw materials. It also produces and sells liver protection drugs and antibiotic products.
Contact
Yuanqu South Road
3rd Floor, Building 4, Industrial Center, No. 5
Zone B, Lhasa Economic and Technological
Development Zone, Tibet Autonomous Region
Lhasa850000
CHNT: +86 8916601760
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
689
Stocks News & Analysis
stocks
A collection of our best stock opportunities
Our latest articles about where we see opportunities in the market.
stocks
Morningstar analyst reacts to Macquarie Group’s earnings
Banking Analyst Nathan Zaia’s analysis of MQG’s results.
stocks
Undervalued ASX share showing progress in global efforts
More clarity on the path forward in the UK.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,936.60 | 26.90 | -0.30% |
| CAC 40 | 7,800.88 | 33.70 | -0.43% |
| DAX 40 | 23,970.36 | 247.14 | -1.02% |
| Dow JONES (US) | 44,837.56 | 64.36 | -0.14% |
| FTSE 100 | 9,081.44 | 38.87 | -0.43% |
| HKSE | 25,332.91 | 229.22 | -0.90% |
| NASDAQ | 21,178.58 | 70.27 | 0.33% |
| Nikkei 225 | 40,623.32 | 374.95 | -0.91% |
| NZX 50 Index | 12,899.26 | 11.48 | -0.09% |
| S&P 500 | 6,389.77 | 1.13 | 0.02% |
| S&P/ASX 200 | 8,675.30 | 22.40 | -0.26% |
| SSE Composite Index | 3,596.42 | 1.52 | -0.04% |